feed,title,long_url,short_url
GN:T:AI,"Capivasertib Improves Survival in AI-Resistant, ER+/HER2- Advanced Breast Cancer - Cancer Therapy Advisor",https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-clinical-oncology-asco/asco-2022/capivasertib-fulvestrant-breast-cancer-survival-treatment-risk/,https://bit.ly/3zjiJin
